Strong growth potential tempts ARC into Chinese medicines investment
This article was originally published in Scrip
Executive Summary
In an indication of rising investor interest in China's traditional medicines sector, the private equity fund ARC Capital Holdings has acquired a minority stake in the Chinese pharma firm Buchang Pharmaceutical Group for $13 million in cash.